Wave Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,102	3,190	1,893	554	608	188
Market Cap Growth	18.42%	68.52%	241.94%	-9.01%	223.83%	-51.05%
Enterprise Value	573.59	2,605	1,617	386.55	559.97	70.17
Last Close Price	5.73	17.00	12.37	5.05	7.00	3.14
PS Ratio	15.36	74.67	17.48	4.89	166.75	4.59
PB Ratio	2.15	6.15	9.04	13.97	-13.49	5.78
P/TBV Ratio	1.99	5.53	8.16	13.52	-12.24	5.01
EV/Sales Ratio	7.99	60.98	14.93	3.41	153.46	1.71
Debt / Equity Ratio	0.01	0.02	0.08	0.53	-0.86	0.62
Net Debt / Equity Ratio	-1.03	-1.13	-1.32	-4.24	1.13	-3.71
Net Debt / EBITDA Ratio	9.97	2.76	2.60	2.67	0.33	1.01
Net Debt / FCF Ratio	2.86	3.11	1.82	8.19	0.39	1.35
Asset Turnover	0.12	0.09	0.35	0.54	0.02	0.17
Quick Ratio	10.93	6.35	2.74	1.19	1.24	2.35
Current Ratio	11.26	6.47	2.89	1.26	1.38	2.53
Return on Equity (ROE)	-10.25%	-54.97%	-73.24%	-1118.17%	-10258.20%	-186.60%
Return on Assets (ROA)	-9.24%	-43.48%	-35.21%	-32.28%	-92.09%	-52.24%
Return on Invested Capital (ROIC)	-96.95%	-236.80%	-73.17%	-48.35%	-189.87%	-109.98%
Return on Capital Employed (ROCE)	-10.48%	-54.90%	-66.96%	-83.24%	-149.51%	-84.39%
Buyback Yield / Dilution	-21.45%	-21.97%	-30.33%	-34.55%	-52.16%	-32.12%
Total Shareholder Return	-21.45%	-21.97%	-30.33%	-34.55%	-52.16%	-32.12%

SEC Filings: 10-K · 10-Q